Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons.

The comparison included separate treatment groups

Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein decreases seen in morphine-tolerant midbrain were not observed in the combination group. The inference depends on the comparator, not simply whether a protein amount was high or low.

The spinal findings differed

Combination-treated animals had higher selected receptor-protein amounts in spinal cord than morphine-tolerant animals. CB1 protein also showed a different pattern in spinal cord and midbrain. Protein abundance is not itself a direct measurement of receptor signaling or a clinical pain outcome.

The causal interpretation remained incomplete

The findings were associated with a short-term antinociceptive profile discussed by the authors. An association between receptor regulation and tolerance does not prove that the protein pattern alone caused the behavioral result or that it will persist during longer exposure.

Interpreting the evidence

The study supports specifying tissue, receptor class and comparison group. It does not establish a safe human combination, a durable opioid-sparing regimen or absence of dependence and other adverse effects. Mouse receptor proteins cannot replace clinical efficacy and safety evidence.

Related reading: interpreting cannabis tolerance claims.

Research reference

Cichewicz DL; Haller VL; Welch SP (2001). Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine. The Journal of pharmacology and experimental therapeutics. PubMed research record.

This analysis draws on the supplied study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us